Group-based trajectories for the analysis of observational cohorts
Schedule
14.03.2019
11:00am to 12:30pm
Location
Room 206, ISPUP
Description

Press here to find the seminar presentation. 

 

Note:

The Seminar is free entry. The request of a certificate and / or declaration of attendance must be ordered on the day of the event at the ISPUP Secretariat.

Speakers
Michael W. Plankey
Affiliation
Georgetown University Medical Center, Full Professor / Senior Investigator, Multicenter AIDS Cohort Study And Women’s Interagency HIV Study, Department of Medicine Division of Infectious Diseases

Michael Plankey is a clinical infectious disease and nutritional epidemiologist and Professor in the Department of Medicine, Division of Infectious Diseases at Georgetown University Medical Center. He is the Co-Investigator for Baltimore-Washington, DC site of the Multicenter AIDS Cohort Study (MACS) in collaboration with Johns Hopkins University Bloomberg School of Public Health and the Washington, DC Consortium of the Women’s Interagency HIV Study (WIHS) at Georgetown University.  He serves as the sole primary investigator funded by both cohorts.  His research expertise has focused on the methodological approaches to analyze complex longitudinal data related to the syndemic production of social, psychological and behavioral risk factors and HIV health outcomes among sexual minority and race/ethnicity minority men and women, evaluation of behavioral, immunological and virological risk factors for hearing and balance loss among HIV-infected compared to HIV-uninfected men and women, and investigation of transient elastography and serum markers to determine the progression and regression post-treatment with direct acting antivirals of liver disease among HIV/HCV mono-infected and co-infected men and women, identification and measurement of psychosocial and behavioral vulnerabilities and resiliencies among aging HIV-infected and uninfected sexual minority men and impact on clinical outcomes related to HIV disease, and investigation of HIV-related myocardial fibrosis and ventricular dysfunction among HIV-infected and uninfected men and women.